Ciliary protein ARL13b detected on RBCs as a potential indicative biomarker of vaso-occlusive crisis and disease severity in SCD: a retrospective pilot study

Read full text Summarise with VIRAT
Authors: Waseem Chauhan, Olivia Fernandez, Nirmish Shah, Amy Pan, Kevin R. Rarick, Ashraf M. Mohieldin, Surya M. Nauli, Sean P. Palecek, Ramani Ramchandran, Rahima Zennadi
Cited by: 0
References: 43

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Abstract Objectives Assessing SCD phenotype is challenging, hindering progress in care and quality of life. Pain crises are the hallmark of SCD, but no reliable prognostic biomarker exists due to its complex pathophysiology. ADP-ribosylation factor-like protein 13b (ARL13b), a small GTPase localized to primary cilia, is present on sickle RBCs and in plasma, therefore RBC-bound ARL13b may thus predict pain crises in SCD. Methods Blood samples from SCD patients were analyzed for ARL13b on RBCs and soluble ARL13b (sARL13b). Retrospective chart reviews tracked hospitalizations for pain crises within 3 months before and after enrollment, hemolysis markers (hemoglobin, bilirubin, lactate dehydrogenase), and disease severity indicators (crisis frequency, acute chest syndrome, kidney disease, cerebrovascular accident). Correlations were calculated between ARL13b measures, pain crises, hemolysis, and severity. Results In our pilot study, significant correlations existed between the percentage of RBCs carrying ARL13b measured on the day of enrollment, and the number of pain crisis experienced by the patients during the 3 months following enrollment (r = 0.3724, P = .0301), and clinical severity score (r = 0.5791, P = .0003). However, no correlation was found between the percentage of RBCs carrying ARL13b or sARL13b with the number of pain crisis experienced by the patients during the 3 months prior to enrollment, Hb, bilirubin, or LDH. Conclusion In this exploratory study, ARL13b detected on sickle RBCs provides not only an objective prognostic biomarker of pain crisis, but also a potentially unbiased predictor of SCD severity.

Fields of Study & Subjects

Hemoglobinopathies and Related Disorders Erythrocyte Function and Pathophysiology Blood groups and transfusion

Publication details

Journal / source
Journal of sickle cell disease.
Volume
3
Issue
1
Publication date
15 January 2026
Language
EN